Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Parkinsonism and mobility deterioration

Medicine of older adults · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Abrupt immobility or dopaminergic withdrawal

Sudden focal weakness, severe dysphagia, aspiration, recurrent falls, autonomic collapse or fever and rigidity after missed Parkinson's medicines may indicate stroke, fracture, sepsis or parkinsonism-hyperpyrexia syndrome.

Action: Use ABCDE and glucose, assess injury, neurology, swallowing, infection and retention, restore time-critical dopaminergic treatment by a safe route with specialist pharmacy or Parkinson's advice, and treat hyperpyrexia or respiratory compromise urgently.

Synopsis

Recognise Parkinsonian syndromes and acute mobility decline, preserve exact time-critical dopaminergic therapy, identify infection, injury, delirium and adverse medicines, and restore transfers, swallowing and community function through specialist multidisciplinary care.

  • Parkinsonism requires bradykinesia plus rigidity, rest tremor or postural instability; tremor alone does not establish Parkinson's disease.
  • A rapid mobility decline is not usual progression: assess missed doses, infection, constipation, retention, dehydration, pain, injury, stroke, posture and new medicines.
  • First-line inpatient safety is exact reconciliation of drug, formulation and individual administration times rather than standard ward-round times.
  • Never stop levodopa or other dopaminergic treatment abruptly; missed therapy can cause profound akinesia, aspiration and parkinsonism-hyperpyrexia syndrome.
  • If oral swallowing is unsafe, obtain same-day Parkinson's and pharmacy advice for dispersible, enteral, transdermal or infusion bridging based on the established regimen.
  • Avoid dopamine-blocking antiemetics and antipsychotics such as metoclopramide, prochlorperazine and haloperidol unless specialist circumstances clearly justify them.
  • Assess wearing-off, dyskinesia and freezing against dose and meal timing before interpreting a single corridor examination.
  • First-line rehabilitation uses Parkinson's-specific physiotherapy for cueing, amplitude, turning, strength and falls, with OT and speech and language support.
  • Measure lying-standing blood pressure and review antihypertensive and dopaminergic contributors while balancing motor control and syncope risk.
  • Driving, cognition, swallowing, bone health, continence, carer strain and advance-care planning belong in ongoing specialist follow-up.

Key red flags

New unilateral weakness, speech change or abrupt ataxia requires emergency stroke assessment rather than Parkinson's attribution.

Fever, severe rigidity, reduced consciousness and autonomic instability after missed levodopa suggests parkinsonism-hyperpyrexia syndrome.

Choking, wet voice, weak cough, weight loss or recurrent chest infection requires urgent swallowing and aspiration assessment.

Painful inability to weight bear after a fall requires occult fracture precautions and imaging.

Syncope, marked orthostatic hypotension or sudden palpitations requires cardiovascular and medication review before mobility progression.

New hallucinations or delirium requires infection, medicines, pain, retention and metabolic assessment before antipsychotic treatment.

Hyperpyrexia syndrome

Fever, profound rigidity, reduced consciousness and autonomic instability follows abrupt dopaminergic interruption.

Acute disease overlay

Abrupt immobility with delirium, pain, focal signs or hypoxia indicates a new medical process.

Investigation priorities

01
Timed medication and motor historyFirst step

Relate deterioration to treatment exposure.

Management branches

First-line acute mobility routeRestore timing and find the new cause

A person with Parkinsonism becomes suddenly slower, rigid or unable to transfer.

  1. Use ABCDE and glucose and assess stroke, injury, infection, pain, retention, loading, dehydration and orthostatic physiology.
  2. Reconcile exact dopaminergic drugs, formulations and personal times and restore safe administration urgently.
  3. Treat the precipitant and begin swallowing, delirium, pressure and mobility support while monitoring return toward baseline.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG71 Parkinson's diseaseTime-critical medicines, specialist review, rehabilitation and non-motor care.
  • NICE CG103 deliriumAcute cognitive change and reversible precipitants.
  • NICE NG127 neurological conditionsUrgent focal and progressive neurological assessment.
  • NICE NG249 falls recommendationsMultifactorial falls and rehabilitation care.
  • British Geriatrics Society CGA HubFunction, cognition, nutrition, carers and transition planning.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom